DOJ Reports Record $6.8 Billion in False Claims Act Recoveries, Driven Largely by Healthcare Enforcement

The federal False Claims Act remains one of the government’s primary civil enforcement tools for addressing fraud involving federal funds, especially considering the scale of federal healthcare program spending. The statute enables the government to seek treble damages and significant per-claim penalties from parties that knowingly submit, or cause the submission of, false or fraudulent claims for payment from the United States. According to the DOJ, enforcement activity in fiscal year 2025 focused heavily on the healthcare sector, including managed care, pharmaceutical pricing and marketing, and medically unnecessary services.

While large pharmaceutical and healthcare organizations continue to be prominent enforcement targets, the DOJ emphasized that liability under the False Claims Act extends across the healthcare industry, including to hospitals, physician groups, and other providers. The record-setting recoveries underscore the government’s ongoing scrutiny of billing, coding, and reimbursement practices, and underscore the need for healthcare stakeholders to maintain strong compliance, monitoring, and internal auditing programs to reduce enforcement risk.

Click Here to read the entire March 2026 Healthcare Law Update now!